The indirect causes, glycogen depletion, dietary changes, blood sugar normalization, are also shared across medications that produce significant weight loss and metabolic improvement
therefore, researchers warn that it carries the identical theoretical risk of exacerbating oncological conditions by promoting new blood vessel formation within tumor microenvironments, rendering it unsafe for use in patients with a history of cancer
I blame myself.
Theres really, really amazing work thats being done
GLP-1 Agonists with Behavioral Therapy Studies suggest that combining pharmacotherapy with structured lifestyle counseling leads to greater long-term success
A characteristic of cancer cells is thought to be metabolic reprogramming, which guarantees a sufficient supply of lipids, proteins, and nucleotides to enable processes of rapid growth and proliferation [5]